BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23034891)

  • 1. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
    Moreno JM; Wojnicz A; Steegman JL; Cano-Abad MF; Ruiz-Nuño A
    Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry.
    Jourdil JF; Tonini J; Stanke-Labesque F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():1-9. PubMed ID: 23384531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of imatinib targeted delivery in human leukocytes.
    Kralj E; Žakelj S; Trontelj J; Pajič T; Preložnik Zupan I; Černelč P; Ostanek B; Marc J; Kristl A
    Eur J Pharm Sci; 2013 Sep; 50(1):123-9. PubMed ID: 23643738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of imatinib in bone marrow and plasma samples of chronic myeloid leukaemia patients using solid phase extraction LC-ESI-MS.
    Iqbal Z; Elliott M; Watson DG; Holyoake T; Jørgensen H
    Pak J Pharm Sci; 2011 Jul; 24(3):285-91. PubMed ID: 21715261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
    Wojnicz A; Colom-Fernández B; Steegmann JL; Muñoz-Calleja C; Abad-Santos F; Ruiz-Nuño A
    Ther Drug Monit; 2017 Jun; 39(3):252-262. PubMed ID: 28490048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
    Zhang M; Moore GA; Fernyhough LJ; Barclay ML; Begg EJ
    Anal Bioanal Chem; 2012 Oct; 404(6-7):2091-6. PubMed ID: 22865010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of erlotinib, gefitinib, and imatinib in human plasma by liquid chromatography tandem mass spectrometry.
    Chahbouni A; den Burger JC; Vos RM; Sinjewel A; Wilhelm AJ
    Ther Drug Monit; 2009 Dec; 31(6):683-7. PubMed ID: 19865001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Titier K; Picard S; Ducint D; Teilhet E; Moore N; Berthaud P; Mahon FX; Molimard M
    Ther Drug Monit; 2005 Oct; 27(5):634-40. PubMed ID: 16175138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.
    Birch M; Morgan PE; Handley S; Ho A; Ireland R; Flanagan RJ
    Biomed Chromatogr; 2013 Mar; 27(3):335-42. PubMed ID: 22886846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of imatinib plasma levels in patients with chronic myeloid leukemia by high performance liquid chromatography-ultraviolet detection and liquid chromatography-tandem mass spectrometry: methods' comparison.
    Awidi A; Salem II; Najib N; Mefleh R; Tarawneh B
    Leuk Res; 2010 Jun; 34(6):714-7. PubMed ID: 19744707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
    Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
    J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple assay for the simultaneous determination of human plasma albendazole and albendazole sulfoxide levels by high performance liquid chromatography in tandem mass spectrometry with solid-phase extraction.
    Wojnicz A; Cabaleiro-Ocampo T; Román-Martínez M; Ochoa-Mazarro D; Abad-Santos F; Ruiz-Nuño A
    Clin Chim Acta; 2013 Nov; 426():58-63. PubMed ID: 24008168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.
    Rezende VM; Rivellis A; Novaes MM; de Alencar Fisher Chamone D; Bendit I
    Drug Des Devel Ther; 2013; 7():699-710. PubMed ID: 23946646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection.
    Widmer N; Béguin A; Rochat B; Buclin T; Kovacsovics T; Duchosal MA; Leyvraz S; Rosselet A; Biollaz J; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):285-92. PubMed ID: 15063337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
    De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1721-6. PubMed ID: 19428316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
    Tan KL; Ankathil R; Gan SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3583-91. PubMed ID: 22000961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry.
    Deng Y; Wong H; Graham RA; Liu W; Shen HS; Shi Y; Wang L; Meng M; Malhi V; Ding X; Dean B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2119-26. PubMed ID: 21704573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPE-UPLC-MS/MS method for sensitive and rapid determination of aripiprazole in human plasma to support a bioequivalence study.
    Patel DP; Sharma P; Sanyal M; Shrivastav PS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():20-5. PubMed ID: 23510852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.